ReNerve Signs Exclusive Partnership with Leading Distributor in Hong Kong to Accelerate International Expansion

Highlights:

• ReNerve Limited has partnered with Accession Medical Supplies Co in an exclusive distribution agreement for sales and marketing in Hong Kong and Macau

• The agreement with Accession marks ReNerve’s further expansion into the Asian market for the Company’s primary product, the NervAlign® Nerve Cuff

• The NervAlign® Nerve Cuff is an FDA cleared product for use on damaged or transected nerves with no gaps or gap closure achieved by flexion

• ReNerve has submitted its application for regulatory approval in Hong Kong

• ReNerve will leverage Accession’s existing relationships with local hospitals and surgeons to drive sales, which in turn will assist in gaining regulatory approval and act as a gateway to the broader Greater Bay Area

• The Global Nerve Repair Biomaterials Market was valued at USD$1.96 billion in 2024 and is projected to grow at a CAGR of 17.8% from 2024 to 2031 to USD$6.19 billion – Source: Global Nerve Repair Biomaterials Market Research Report, 2020-2031

ReNerve Limited (ASX:RNV, “ReNerve” or “the Company”) is pleased to announce that it has signed an exclusive distribution partnership (“the Agreement”) with a leading supplier of medical devices in Hong Kong, Accession Medical Supplies Co. (“Accession”), for the sales and marketing of its NervAlign® Nerve Cuff.

As part of the Agreement, Accession will purchase the ReNerve product range as a wholesaler, with ReNerve supporting Accession in its sales and marketing activities. The two companies will work together to gain regulatory approval in Hong Kong by leveraging Accession’s existing relationships with local hospitals and day surgeries to drive sales and increase product demand as adoption increases. ReNerve also announces that it has filed for regulatory approval in Hong Kong and anticipates approval to be granted in mid-2025.

Dr. Julian Chick, Managing Director of ReNerve, commented:
“The exclusive partnership with Accession represents a pivotal step forward in ReNerve’s growth strategy. By leveraging Accession’s extensive local expertise and established relationships with key hospitals and surgeons in Hong Kong and Macau, we are confident in our ability to successfully introduce and expand the reach of the NervAlign® Nerve Cuff in this dynamic market. This collaboration not only accelerates our international expansion but also positions ReNerve to tap into the broader Greater Bay Area, unlocking significant opportunities for growth. As we continue to advance our innovative solutions for nerve repair, this partnership underscores our commitment to improving patient outcomes and driving sustainable value for our stakeholders.”